These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 9375997)

  • 1. Substance abuse and mental health care. Managed care, access, and clinical outcomes.
    Kelly JA
    AAOHN J; 1997 Sep; 45(9):439-45. PubMed ID: 9375997
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Managed care, networks and trends in hospital care for mental health and substance abuse treatment in Massachusetts: 1994-1999.
    Fleming E; Lien H; Ma CT; McGuire TG
    J Ment Health Policy Econ; 2003 Mar; 6(1):3-12. PubMed ID: 14578543
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Managed care and the quality of substance abuse treatment.
    Shepard DS; Daley M; Ritter GA; Hodgkin D; Beinecke RH
    J Ment Health Policy Econ; 2002 Dec; 5(4):163-74. PubMed ID: 14578550
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Is conventional wisdom wrong? Coverage for substance abuse treatment under Medicaid managed care.
    Maglione M; Ridgely MS
    J Subst Abuse Treat; 2006 Jun; 30(4):285-90. PubMed ID: 16716842
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Managed care risk contracts and substance abuse treatment.
    Sturm R
    Inquiry; 2000; 37(2):219-25. PubMed ID: 10985114
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New directions in alcohol and drug treatment under managed care.
    Weisner C; McCarty D; Schmidt L
    Am J Manag Care; 1999 Jun; 5 Spec No():SP57-69. PubMed ID: 10538861
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The impact of publicly funded managed care on adolescent substance abuse treatment outcomes.
    Harrow BS; Tompkins CP; Mitchell PD; Smith KW; Soldz S; Kasten L; Fleming K
    Am J Drug Alcohol Abuse; 2006; 32(3):379-98. PubMed ID: 16864469
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The impact of managed behavorial healthcare on the costs of psychiatric and chemical dependency treatment.
    Geraty R; Bartlett J; Hill E; Lee F; Shusterman A; Waxman A
    Behav Healthc Tomorrow; 1994; 3(2):18-30. PubMed ID: 10172255
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Public substance abuse and managed behavioral healthcare. American Managed Behavioral Healthcare Association and National Association of State Alcohol and Drug Abuse Directors, Inc.
    Behav Healthc Tomorrow; 1999 Feb; 8(1):25-30. PubMed ID: 10346117
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Organizational and client determinants of cost in outpatient substance abuse treatment.
    Beaston-Blaakman A; Shepard D; Horgan C; Ritter G
    J Ment Health Policy Econ; 2007 Mar; 10(1):3-13. PubMed ID: 17417043
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The impact of managed care on publicly funded outpatient adolescent substance abuse treatment: service use and six-month outcomes in Oregon and Washington.
    Carlson MJ; Gabriel RM; Deck DD; Laws KE; D'Ambrosio R
    Med Care Res Rev; 2005 Jun; 62(3):320-38. PubMed ID: 15894707
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Outcomes for clients of public substance abuse treatment programs before and after Medicaid managed care.
    McFarland BH; McCamant LE; Barron NM
    J Subst Abuse Treat; 2005 Mar; 28(2):149-57. PubMed ID: 15780545
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of managed care on access to mental health services among Medicaid enrollees receiving substance treatment.
    Bigelow DA; McFarland BH; McCamant LE; Deck DD; Gabriel RM
    Psychiatr Serv; 2004 Jul; 55(7):775-9. PubMed ID: 15232016
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The impacts of mental health parity and managed care in one large employer group: a reexamination.
    Zuvekas SH; Rupp AE; Norquist GS
    Health Aff (Millwood); 2005; 24(6):1668-71. PubMed ID: 16284042
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Managed care and case management of substance abuse treatment.
    Woodward A
    NIDA Res Monogr; 1992; 127():34-53. PubMed ID: 1436002
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cost-effectiveness analysis of integrated care for people with HIV, chronic mental illness and substance abuse disorders.
    Weaver MR; Conover CJ; Proescholdbell RJ; Arno PS; Ang A; Uldall KK; Ettner SL
    J Ment Health Policy Econ; 2009 Mar; 12(1):33-46. PubMed ID: 19346565
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Can encouraging substance abuse patients to participate in self-help groups reduce demand for health care? A quasi-experimental study.
    Humphreys K; Moos R
    Alcohol Clin Exp Res; 2001 May; 25(5):711-6. PubMed ID: 11371720
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Integrating an outcomes information system into managed care for substance abuse.
    Kane RL; Bartlett J; Potthoff S
    Behav Healthc Tomorrow; 1994; 3(3):57-61. PubMed ID: 10172242
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Substance abuse treatment: outcomes of managed care techniques.
    Chung R; Filstead WJ
    Behav Healthc Tomorrow; 1995; 4(6):78-9, 58. PubMed ID: 10172617
    [No Abstract]   [Full Text] [Related]  

  • 20. Guideline recommendations for treatment of schizophrenia: the impact of managed care.
    Dickey B; Normand SL; Hermann RC; Eisen SV; Cortes DE; Cleary PD; Ware N
    Arch Gen Psychiatry; 2003 Apr; 60(4):340-8. PubMed ID: 12695310
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.